Updated: May 13, 2024
The average Kymera Therapeutics stock price target is 43.91 with a max estimate of 56.00 and a min estimate of 30.00
Review Kymera Therapeutics earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: May 13, 2024